THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans
(PubMed) Ziegler D, Hanefeld M, Ruhnau KJ, et al
Due to a lack of clinical trials, there is a shortage of data on the safety of BPC-157 for use in humans
Approximately 159.21 Da refers to the free positively charged component, while approximately 286.11 g/mol includes the iodide counterion
GHK-Cu shelf life depends heavily on storage conditions
The patient is injecting a product with a known composition under medical supervision